Download PDF
Thromb Haemost 1994; 72(04): 582-587
DOI: 10.1055/s-0038-1648919
Original Article
Schattauer GmbH Stuttgart

A Chromogenic Test to Determine the Procoagulant Phospholipids in Platelet-rich Plasma and Whole Blood

R J Wagenvoord
The Department of Biochemistry, Faculty II, University of Limburg, Maastricht, The Netherlands
,
H H Hendrix
The Department of Biochemistry, Faculty II, University of Limburg, Maastricht, The Netherlands
,
Hu Kai
The Department of Biochemistry, Faculty II, University of Limburg, Maastricht, The Netherlands
,
H C Hemker
The Department of Biochemistry, Faculty II, University of Limburg, Maastricht, The Netherlands
› Author Affiliations
Further Information

Publication History

Received 13 April 1994

Accepted after revision 15 June 1994

Publication Date:
06 July 2018 (online)

Also available at
  PDF Download  Permissions and Reprints

Summary

We have developed a chromogenic assay to measure the phospholipid-related procoagulant activity (PPA) in whole blood, or platelet-rich plasma. The test is based upon thrombin formation from prothrombin by prothrombinase and is designed in such a way that procoagulant lipids are rate limiting for the prothrombinase activity. In the chromogenic test PPA concentrations equivalent to 0-10 nM phospholipid vesicles containing 75% phosphatidyl choline (PC) and 25% phosphatidyl serine (PS) can be measured.

The thrombin, which develops during the test, is measured with a chromogenic substrate. By the action of thrombin on this chromogenic substrate p-nitroaniline is liberated, which causes an increase in absorbance. Thrombin formed in the assay mixture activates the present platelets. This causes a linear increase of the velocity of thrombin generation during the test, i. e. a parabolic increase of product formation. For that reason the thrombin generation in time is characterized by two parameters, the basal PPA (PPA-B) of the original mixture and the increase in PPA due to platelet activation (PPA-A). To determine these figures the absorbency-data were fitted to parabolas. In most cases the contribution of PPA-A to the total amount of formed thrombin becomes considerable already after 30 s.

Preliminary tests show that PPA-B activity in whole blood or platelet-rich plasma of patients with a thrombotic disorder is significantly higher than the activity of a control group of the same age.

 

  • References

  • 1 Bevers EM, Comfurius P, Van Rijn JLML, Hemker HC, Zwaal RFA. Generation of prothrombin-converting activity and the exposure of phos-phatidylserine at the outer surface of platelets. Eur J Biochem 1982; 122: 429-436
    CrossrefPubMedGoogle Scholar
  • 2 Bevers EM, Comfurius P, Zwaal RFA. Changes in membrane phospholipid distribution during platelet activation. Biochim Biophys Acta 1983; 736: 57-66
    CrossrefPubMedGoogle Scholar
  • 3 Zwaal RFA, Bevers EM. Platelet phospholipid asymmetry and its significance in hemostasis. Subcell Biochem 1983; 9: 299-334
    PubMedGoogle Scholar
  • 4 Bevers EM, Rosing J, Zwaal RFA. Development of procoagulant binding sites on the platelet surface. Adv Exp Med Biol 1985; 192: 359-371
    PubMedGoogle Scholar
  • 5 Van Dieijen G, Tans G, Rosing J, Hemker HC. The role of phospholipid and factor VIIIa in the activation of bovine factor X. J Biol Chem 1981; 256: 3433-3442
    CrossrefPubMedGoogle Scholar
  • 6 Mertens K, Bertina RM. The contribution of Ca2+ and phospholipids to the activation of human blood-coagulation factor X by activated factor IX. Biochem J 1984; 223: 607-615
    CrossrefPubMedGoogle Scholar
  • 7 Van Dieijen G, Van Rijn JLML, Govers-Riemslag JWP, Hemker HC, Rosing J. Assembly of the intrinsic factor X activating complex: Interactions between factor IXa, factor VIIIa and phospholipid. Thromb Haemost 1985; 53: 396-400
    Article in Thieme ConnectPubMedGoogle Scholar
  • 8 Esmon CT, Owen WG, Jackson CM. A plausible mechanism for prothrombin activation by factor Xa, factor Va, phospholipid and calcium ions. J Biol Chem 1974; 249: 8045-8057
    PubMedGoogle Scholar
  • 9 Rosing J, Tans G, Govers-Riemslag JWP, Zwaal RFA, Hemker HC. The role of phospholipids and factor Va in the prothrombinase complex. J Biol Chem 1980; 255: 274-283
    PubMedGoogle Scholar
  • 10 Van Rijn JLML, Govers-Riemslag JWP, Zwaal RFA, Rosing J. Kinetic studies of prothrombin activation: Effect of factor Va and phospholipids on the formation of the enzyme substrate complex. Biochemistry 1984; 23: 4557-4563
    CrossrefPubMedGoogle Scholar
  • 11 Krishnaswamy S, Jones KC, Mann KG. Prothrombinase complex assembly. Kinetic mechanism of enzyme assembly on phospholipid vesicles. J Biol Chem 1988; 263: 3823-3834
    PubMedGoogle Scholar
  • 12 Van Rijn J, Rosing J, Van Dieijen G. Activity of human blood platelets in prothrombin and in factor X activation induced by ionophore A23187. Eur J Biochem 1983; 133: 1-10
    CrossrefPubMedGoogle Scholar
  • 13 Jesty J, Beltrami E, Willems G. Mathematical analysis of a proteolytic positive-feedback loop: Dependence of lag time and enzyme yields on the initial conditions and kinetic parameters. Biochemistry 1993; 32: 6266-6274
    CrossrefPubMedGoogle Scholar
  • 14 Bevers EM, Tilly RH, Senden JMG, Comfurius P, Zwaal RFA. Exposure of endogenous phosphatidylserine at the outer surface of stimulated platelets is reversed by restoration of amino-phospholipid translocase activity. Biochemistry 1989; 28: 2382-2387
    CrossrefPubMedGoogle Scholar
  • 15 Comfurius P, Senden JM, Tilly RH, Schroit AJ, Bevers EM, Zwaal RFA. Loss of membrane phospholipid asymmetry in platelets and red cells may be associated with calcium-induced shedding of plasma membrane and inhibition of aminophospholipid translocase. Biochim Biophys Acta 1990; 1026 (02) 153-160
    CrossrefPubMedGoogle Scholar
  • 16 Bajaj SP, Harmony JAK, Martin-Carrion M, Castellino FJ. Human plasma lipoproteins as accelerators of prothrombin activation. J Biol Chem 1976; 251: 5233-5236
    PubMedGoogle Scholar
  • 17 Fujikawa K, Legaz ME, Davie EW. Bovine factor X1 and X2 (Stuart factor). Isolation and characterization. Biochemistry 1972; 11: 4882-4891
    CrossrefPubMedGoogle Scholar
  • 18 Fujikawa K, Legaz ME, Davie EW. Bovine factor X1 (Stuart factor). Mechanism of activation by a protein from Russell’s viper venom. Biochemistry 1972; 11: 4892-4899
    PubMedGoogle Scholar
  • 19 Owen WG, Esmon CT, Jackson CM. The conversion of prothrombin to thrombin. I. Characterization of the reaction products formed during the activation of bovine prothrombin. J Biol Chem 1974; 249: 594-605
    PubMedGoogle Scholar
  • 20 Wagenvoord RJ, Hendrix H, Soria C, Hemker HC. Localization of the inhibitory site(s) of pentosan polysulphate in blood coagulation. Thromb Haemost 1988; 60: 220-225
    Article in Thieme ConnectPubMedGoogle Scholar
  • 21 Lindhout T, Govers-Riemslag JWP, Van de Waart P, Hemker HC, Rosing J. Factor Va-Factor Xa interaction. Effects of phospholipid vesicles of varying composition. Biochemistry 1982; 21: 5494-5502
    PubMedGoogle Scholar
  • 22 Comfurius P, Zwaal RFA. The enzymatic synthesis of phosphatidyl serine and purification by CM-cellulose column chromatography. Biochim Biophys Acta 1977; 488: 36-42
    CrossrefPubMedGoogle Scholar
  • 23 Bottcher CJF, Van Gent CM, Pries C. A rapid and sensitive submicrophosphorus determination. Anal Chim Acta 1961; 24: 203-207
    CrossrefPubMedGoogle Scholar
  • 24 van Rijn JLML, Govers-Riemslag JWP, Zwaal RFA, Rosing J. Kinetic studies of prothrombin activation: Effect of factor Va and phospholipids on the formation of the enzyme substrate complex. Biochemistry 1984; 23: 4557-4563
    CrossrefPubMedGoogle Scholar
  • 25 Workman Jr EF, Lundblad RL. The effect of monovalent cations on the catalytic activity of thrombin. Arch Biochem Biophys 1978; 185 (02) 544-548
    CrossrefPubMedGoogle Scholar
  • 26 Kane WH, Lindhout MJ, Jackson CM, Majerus PW. Factor Va-dependent binding of factor Xa to human platelets. J Biol Chem 1980; 3: 1170-1174
    PubMedGoogle Scholar
  • 27 Chesney CM, Pifer DD, Colman RW. Subcellular localization and secretion of factor V from human platelets. Proc Natl Acad Sci USA 1981; 78: 5180-5184
    CrossrefPubMedGoogle Scholar
  • 28 Rosing J, Van Rijn JLML, Bevers EM, Van Dieijen G, Comfurius P, Zwaal RFA. The role of activated human platelets in prothrombin and factor X activation. Blood 1965; 319-332
    PubMedGoogle Scholar
  • 29 Baruch D, Hemker HC, Lindhout T. Kinetics of thrombin-induced release and activation of platelet factor V. Eur J Biochem 1986; 154: 213-218
    CrossrefPubMedGoogle Scholar